chr5-69365224-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003187.5(TAF9):c.514G>A(p.Val172Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003187.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF9 | NM_003187.5 | c.514G>A | p.Val172Ile | missense_variant | Exon 3 of 3 | ENST00000217893.10 | NP_003178.1 | |
AK6 | NM_016283.5 | c.121+1279G>A | intron_variant | Intron 2 of 4 | ENST00000380822.9 | NP_057367.1 | ||
TAF9 | NM_001015892.2 | c.514G>A | p.Val172Ile | missense_variant | Exon 3 of 3 | NP_001015892.1 | ||
AK6 | NM_001015891.2 | c.112+1279G>A | intron_variant | Intron 2 of 4 | NP_001015891.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF9 | ENST00000217893.10 | c.514G>A | p.Val172Ile | missense_variant | Exon 3 of 3 | 1 | NM_003187.5 | ENSP00000217893.7 | ||
AK6 | ENST00000380822.9 | c.121+1279G>A | intron_variant | Intron 2 of 4 | 1 | NM_016283.5 | ENSP00000370201.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727248
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.514G>A (p.V172I) alteration is located in exon 3 (coding exon 1) of the TAF9 gene. This alteration results from a G to A substitution at nucleotide position 514, causing the valine (V) at amino acid position 172 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.